These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37742362)

  • 21. Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells.
    Zhou H; Yang L; Li H; Gong H; Cheng L; Zheng H; Zhang LM; Lan Y
    Int J Nanomedicine; 2012; 7():4649-60. PubMed ID: 22942646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra-articular injection of triamcinolone acetonide releasing biomaterial microspheres inhibits pain and inflammation in an acute arthritis model.
    Rudnik-Jansen I; Schrijver K; Woike N; Tellegen A; Versteeg S; Emans P; Mihov G; Thies J; Eijkelkamp N; Tryfonidou M; Creemers L
    Drug Deliv; 2019 Dec; 26(1):226-236. PubMed ID: 30843733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the hypothalamic-pituitary-adrenal axis susceptibility upon single-dose i.m. depot versus long-acting i.v. triamcinolone acetonide therapy: a direct pharmacokinetic correlation.
    Abraham G; Demiraj F; Ungemach FR
    J Endocrinol; 2006 Nov; 191(2):491-6. PubMed ID: 17088419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring triamcinolone acetonide in aqueous humor by gas chromatography-electron-capture negative-ion mass spectrometry.
    Chu KO; Ho TC; Chiang WY; Wang CC; Lam DS; Pang CP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):199-204. PubMed ID: 17097356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of micronization method on the performance of a suspension triamcinolone acetonide pressurized metered-dose inhaler formulation.
    Williams RO; Brown J; Liu J
    Pharm Dev Technol; 1999 May; 4(2):167-79. PubMed ID: 10231878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis.
    Guo D; Li Q; Sun Y; Guo J; Zhao Q; Yin X; Wei H; Wu S; Bi H
    Nanotechnology; 2019 Apr; 30(16):165702. PubMed ID: 30641491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery.
    Altamirano-Vallejo JC; Navarro-Partida J; Gonzalez-De la Rosa A; Hsiao JH; Olguín-Gutierrez JS; Gonzalez-Villegas AC; Keller BC; Bouzo-Lopez L; Santos A
    J Ocul Pharmacol Ther; 2018 Jun; 34(5):416-425. PubMed ID: 29584529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycosylation-enhanced biocompatibility of the supramolecular hydrogel of an anti-inflammatory drug for topical suppression of inflammation.
    Xiong T; Li X; Zhou Y; Song Q; Zhang R; Lei L; Li X
    Acta Biomater; 2018 Jun; 73():275-284. PubMed ID: 29660509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical treatment of the buccal mucosa and wounded skin in rats with a triamcinolone acetonide-loaded hydrogel prepared using an electron beam.
    Choi SG; Baek EJ; Davaa E; Nho YC; Lim YM; Park JS; Gwon HJ; Huh KM; Park JS
    Int J Pharm; 2013 Apr; 447(1-2):102-8. PubMed ID: 23467084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of alkanediols on the release of triamcinolone acetonide from semisolid dosage forms.
    Sigg M; Daniels R
    Int J Pharm; 2021 Aug; 605():120843. PubMed ID: 34216765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
    Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
    Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deposition and pharmacokinetics of an HFA formulation of triamcinolone acetonide delivered by pressurized metered dose inhaler.
    Hirst PH; Pitcairn GR; Richards JC; Rohatagi S; Gillen MS; Newman SP
    J Aerosol Med; 2001; 14(2):155-65. PubMed ID: 11681648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal concentration and clearance of triamcinolone acetonide in nonvitrectomized human eyes.
    Mason JO; Somaiya MD; Singh RJ
    Retina; 2004 Dec; 24(6):900-4. PubMed ID: 15579987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rufinamide-Loaded Chitosan Nanoparticles in Xyloglucan-Based Thermoresponsive
    Dalvi A; Ravi PR; Uppuluri CT
    Front Pharmacol; 2021; 12():691936. PubMed ID: 34234679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-Delivery of Atorvastatin Nanocrystals in PLGA based in situ Gel for Anti-Hyperlipidemic Efficacy.
    Kurakula M; Ahmed TA
    Curr Drug Deliv; 2016; 13(2):211-20. PubMed ID: 26549039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A stepwise optimization strategy to formulate
    Elmotasem H; Awad GEA
    Asian J Pharm Sci; 2020 Sep; 15(5):617-636. PubMed ID: 33193864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
    Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
    Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged inhibition of inflammation in osteoarthritis by triamcinolone acetonide released from a polyester amide microsphere platform.
    Rudnik-Jansen I; Colen S; Berard J; Plomp S; Que I; van Rijen M; Woike N; Egas A; van Osch G; van Maarseveen E; Messier K; Chan A; Thies J; Creemers L
    J Control Release; 2017 May; 253():64-72. PubMed ID: 28284832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers.
    Jiang G; Jia H; Qiu J; Mo Z; Wen Y; Zhang Y; Wen Y; Xie Q; Ban J; Lu Z; Chen Y; Wu H; Ni Q; Chen F; Lu J; Wang Z; Li H; Chen J
    Int J Nanomedicine; 2020; 15():9373-9387. PubMed ID: 33262593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
    Ahmed TA; Aljaeid BM
    Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.